0001395064-24-000143.txt : 20240710 0001395064-24-000143.hdr.sgml : 20240710 20240710071538 ACCESSION NUMBER: 0001395064-24-000143 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TAKEDA PHARMACEUTICAL CO LTD CENTRAL INDEX KEY: 0001395064 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38757 FILM NUMBER: 241108681 BUSINESS ADDRESS: STREET 1: 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU CITY: TOKYO STATE: M0 ZIP: 103-8668 BUSINESS PHONE: 81332782111 MAIL ADDRESS: STREET 1: 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU CITY: TOKYO STATE: M0 ZIP: 103-8668 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Platford Giles Richard CENTRAL INDEX KEY: 0001977620 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 650 E. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001977620 XXXXXXXX LIVE 0001395064 Takeda Pharmaceutical Company Limited 001-38757 1-1, Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo M0 103-8668 81-3-3278-2306 Giles Richard Platford President, Plasma-Derived Therapies Business Unit American Depositary Shares (ADSs) Interactive Brokers LLC

One Pickwick Plaza Greenwich CT 06830

20721 273102.78 120169678 07/11/2024 NYSE ADSs 07/01/2024 Restricted Stock Unit Awards - Vested. Takeda Pharmaceutical Company Limited N 74992 07/01/2024 Compensation Y 07/10/2024 /s/ Giles Richard Platford